fbpx

Style Sampler

Layout Style

Patterns for Boxed Mode

Backgrounds for Boxed Mode

All fields are required.

Close Appointment form
Working Towards Quality Medical Care for the Future

Covid Treatment

Pfizer is now offering an orally administered drug for those who have tested positive for COVID-19 in the past 3-5 days. Eligible participants of this study, with a confirmed diagnosis of COVID-19 (SARS-CoV-2), will be placed in two groups (1:1). Each group will receive an investigational antiviral drug or the placebo, every 12 hours for 5 days (10 doses total).

Minimum Inclusion:

  • Must be at least 19 years old
  • Have initial onset of signs/symptoms attributable to COVID-19
  • A confirmed SARS-CoV-2 (COVID-19) test
  • Other criteria may apply*

Eligible candidates will be compensated for time and travel.

To learn more about this trial and to find out if you qualify, please call 402.934.0044 or complete the form on our contact page.